🧵 1. Danish drugmaker Novo Nordisk briefly overtakes LVMH as Europe's most valuable company, driven by demand for its diabetes and weight-loss drugs. #business
🧵 1. Danish drugmaker Novo Nordisk briefly overtakes LVMH as Europe's most valuable company, driven by demand for its diabetes and weight-loss drugs. #business
🧵 2. LVMH, the world's biggest luxury retailer, loses top spot due to concerns over Chinese economy. Novo's success shows a shift in market priorities.
🧵 3. Novo Nordisk's shares surge 17% on positive results of a study highlighting cardiovascular benefits of its weight-loss drug, Wegovy.
🧵 4. Market capitalization battle: Novo Nordisk reaches $421 billion in market cap, inching ahead of LVMH's $420.97 billion. LVMH regains lead later, with values at $423.9 billion and $421.9 billion, respectively.
🧵 5. Novo Nordisk's strategy garners investor appreciation as obesity drug market is projected to hit $100 billion in annual sales. Eli Lilly also set to enter with its drug Mounja.
🧵 Read more at: https://www.reuters.com/markets/europe/drugmaker-novo-nordisk-briefly-overtakes-lvmh-europes-most-valuable-company-2023-09-01/